HomeNewsBusinessStocksHDFC Securities positive on Divis, Cadila; neutral on Sun Pharma

HDFC Securities positive on Divis, Cadila; neutral on Sun Pharma

In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his readings and outlook on a few of the pharma stocks.

May 29, 2017 / 11:02 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

first published: May 29, 2017 09:48 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!